BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Deng GL, Zeng S, Shen H. Chemotherapy and target therapy for hepatocellular carcinoma: New advances and challenges. World J Hepatol 2015; 7(5): 787-798 [PMID: 25914779 DOI: 10.4254/wjh.v7.i5.787]
URL: https://www.wjgnet.com/1948-5182/full/v7/i5/787.htm
Number Citing Articles
1
Joaquim Moreno-Càceres, Isabel Fabregat. Apoptosis in liver carcinogenesis and chemotherapyHepatic Oncology 2015; 2(4): 381 doi: 10.2217/hep.15.27
2
HAO TANG, RONG-PING LI, PING LIANG, YA-LONG ZHOU, GUANG-WEI WANG. miR-125a inhibits the migration and invasion of liver cancer cells via suppression of the PI3K/AKT/mTOR signaling pathwayOncology Letters 2015; 10(2): 681 doi: 10.3892/ol.2015.3264
3
Jella-Andrea Abraham, Olga Golubnitschaja. Time for paradigm change in management of hepatocellular carcinoma: is a personalized approach on the horizon?Personalized Medicine 2016; 13(5): 455 doi: 10.2217/pme-2016-0013
4
Zhongqiang Zhang, Xiao Tan, Jing Luo, Hongliang Yao, Zhongzhou Si, Jing-Shan Tong. The miR-30a-5p/CLCF1 axis regulates sorafenib resistance and aerobic glycolysis in hepatocellular carcinomaCell Death & Disease 2020; 11(10) doi: 10.1038/s41419-020-03123-3
5
Fan Wu, Wei‐Jia Chen, Lun Yan, Guo‐Qian Tan, Wei‐Tao Li, Xuan‐Jin Zhu, Xiao‐Chuan Ge, Jian‐Wei Liu, Bai‐Lin Wang. Mus81 knockdown improves chemosensitivity of hepatocellular carcinoma cells by inducing S‐phase arrest and promoting apoptosis through CHK 1 pathway Cancer Medicine 2016; 5(2): 370 doi: 10.1002/cam4.588
6
Jesús Rafael Rodríguez-Aguilera, Rebeca Pérez-Cabeza de Vaca, Nuria Guerrero-Celis, Gabriela Velasco-Loyden, Mariana Domínguez-López, Félix Recillas-Targa, Victoria Chagoya de Sánchez. Liver Cirrhosis - Debates and Current Challenges2019;  doi: 10.5772/intechopen.83481
7
Yibin Deng, Zhongheng Wei, Meijin Huang, Guidan Xu, Wujun Wei, Bin Peng, Shunqiang Nong, Houji Qin. Long non‐coding RNA F11‐AS1 inhibits HBV‐related hepatocellular carcinoma progression by regulating NR1I3 via binding to microRNA‐211‐5p Journal of Cellular and Molecular Medicine 2020; 24(2): 1848 doi: 10.1111/jcmm.14881
8
Wan-Jiang Xue, Ying Feng, Fei Wang, Yi-Bing Guo, Peng Li, Lei Wang, Yi-Fei Liu, Zhi-Wei Wang, Yu-Min Yang, Qin-Sheng Mao. Asialoglycoprotein receptor-magnetic dual targeting nanoparticles for delivery of RASSF1A to hepatocellular carcinomaScientific Reports 2016; 6(1) doi: 10.1038/srep22149
9
Chen-Jei Tai, Alagie Jassey, Ching-Hsuan Liu, Cheng-Jeng Tai, Christopher D. Richardson, Shu Hui Wong, Liang-Tzung Lin. Targeting Autophagy Augments Berberine-Mediated Cell Death in Human Hepatoma Cells Harboring Hepatitis C Virus RNACells 2020; 9(4): 908 doi: 10.3390/cells9040908
10
Qiang Fei, Feihong Song, Xinwei Jiang, Han Hong, Xiaoyong Xu, Zhengkang Jin, Xiang Zhu, Binghua Dai, Jiamei Yang, Chengjun Sui, Minhui Xu. LncRNA ST8SIA6-AS1 promotes hepatocellular carcinoma cell proliferation and resistance to apoptosis by targeting miR-4656/HDAC11 axisCancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-01325-5
11
Wu Bi, Ji-chang Xiao, Rui-jie Liu, Liu-ying Zhou, Sai Zhang, Mei Yang, Peng-fei Zhang. Identification of a 3,3-difluorinated tetrahydropyridinol compound as a novel antitumor agent for hepatocellular carcinoma acting via cell cycle arrest through disturbing CDK7-mediated phosphorylation of Cdc2Investigational New Drugs 2020; 38(2): 287 doi: 10.1007/s10637-019-00792-6
12
Surbhi Chouhan, Snahlata Singh, Dipti Athavale, Pranay Ramteke, Muralidharan Vanuopadath, Bipin G Nair, Sudarslal Sadasivan Nair, Manoj Kumar Bhat. Sensitization of hepatocellular carcinoma cells towards doxorubicin and sorafenib is facilitated by glucose-dependent alterations in reactive oxygen species, P-glycoprotein and DKK4Journal of Biosciences 2020; 45(1) doi: 10.1007/s12038-020-00065-y
13
Jian Zhang, Xiuxiu Wang, Liang Cheng, Jiandong Yuan, Zhiyuan Zhong. SP94 peptide mediating highly specific and efficacious delivery of polymersomal doxorubicin hydrochloride to hepatocellular carcinoma in vivoColloids and Surfaces B: Biointerfaces 2021; 197: 111399 doi: 10.1016/j.colsurfb.2020.111399
14
Hongzhi Du, Yang Liu, Xudong Chen, Xiaowen Yu, Xiaoying Hou, Hongyang Li, Meixiao Zhan, Sensen Lin, Ligong Lu, Shengtao Yuan, Li Sun. DT-13 synergistically potentiates the sensitivity of gastric cancer cells to topotecan via cell cycle arrest in vitro and in vivoEuropean Journal of Pharmacology 2018; 818: 124 doi: 10.1016/j.ejphar.2017.10.014
15
Yuanyuan Liu, Zhou Zhou, Xi Lin, Xiaofeng Xiong, Rui Zhou, Minglu Zhou, Yuan Huang. Enhanced Reactive Oxygen Species Generation by Mitochondria Targeting of Anticancer Drug To Overcome Tumor Multidrug ResistanceBiomacromolecules 2019; 20(10): 3755 doi: 10.1021/acs.biomac.9b00800
16
Jie Su, Linlin Jiang, Jingna Wu, Zhiyu Liu, Yuping Wu. Anti-tumor and anti-virus activity of polysaccharides extracted from Sipunculus nudus(SNP) on Hepg2.2.15International Journal of Biological Macromolecules 2016; 87: 597 doi: 10.1016/j.ijbiomac.2016.03.022
17
Kin Fong Lei, Tai-Kun Liu, Ngan-Ming Tsang. Towards a high throughput impedimetric screening of chemosensitivity of cancer cells suspended in hydrogel and cultured in a paper substrateBiosensors and Bioelectronics 2018; 100: 355 doi: 10.1016/j.bios.2017.09.029
18
Bingling Dai, Yujiao Ma, Tianfeng Yang, Mengying Fan, Runze Yu, Qi Su, Hongying Wang, Feng Liu, Changhua Yang, Yanmin Zhang. Synergistic effect of berberine and HMQ1611 impairs cell proliferation and migration by regulating Wnt signaling pathway in hepatocellular carcinomaPhytotherapy Research 2019; 33(3): 745 doi: 10.1002/ptr.6267
19
Yuee Cai, Yingqi Xu, Hon Fai Chan, Xiaobin Fang, Chengwei He, Meiwan Chen. Glycyrrhetinic Acid Mediated Drug Delivery Carriers for Hepatocellular Carcinoma TherapyMolecular Pharmaceutics 2016; 13(3): 699 doi: 10.1021/acs.molpharmaceut.5b00677
20
Po‐Han Tseng, Zong‐Lin Sie, Meng‐Chieh Liu, Han‐Syuan Lin, Wan‐Yu Yang, Ting‐Yu Lin, Hsing‐Pang Hsieh, Shih‐Che Hung, Chia‐Liang Cheng, Horng‐Dar Wang, Hsin‐Hou Chang, Chiou‐Hwa Yuh. Identification of Two Novel Small Compounds that Inhibit Liver Cancer Formation in Zebrafish and Analysis of Their Conjugation to Nanodiamonds to Further Reduce ToxicityAdvanced Therapeutics 2019; 2(12): 1900105 doi: 10.1002/adtp.201900105
21
Hong-Bin Xu, Jun Fu, Fang Huang, Jing Yu. Guggulsterone sensitized drug-resistant human hepatocarcinoma cells to doxorubicin through a Cox-2/P-gp dependent pathwayEuropean Journal of Pharmacology 2017; 803: 57 doi: 10.1016/j.ejphar.2017.03.045
22
F. Rahimi-Moghaddam, N. Azarpira, N. Sattarahmady. Evaluation of a nanocomposite of PEG-curcumin-gold nanoparticles as a near-infrared photothermal agent: an in vitro and animal model investigationLasers in Medical Science 2018; 33(8): 1769 doi: 10.1007/s10103-018-2538-1
23
Shrikant Barot, Ehab M. Abo-Ali, Daisy L. Zhou, Christian Palaguachi, Vikas V. Dukhande. Inhibition of glycogen catabolism induces intrinsic apoptosis and augments multikinase inhibitors in hepatocellular carcinoma cellsExperimental Cell Research 2019; 381(2): 288 doi: 10.1016/j.yexcr.2019.05.017
24
Yuanmin Pei, Xueling Sun, Xiwei Guo, Huashan Yin, Le Wang, Fugu Tian, Hongxi Jing, Xiaobo Liang, Jun Xu, Pengcheng Shi. FGF8 promotes cell proliferation and resistance to EGFR inhibitors via upregulation of EGFR in human hepatocellular carcinoma cellsOncology Reports 2017; 38(4): 2205 doi: 10.3892/or.2017.5887
25
Fujun Jin, Rongze Wang, Yexuan Zhu, Jingyi Chen, Wei Cao, Yiliang Wang, Yanting Wu, Xiaowei Song, Yunsheng Huang, Jun Dong, Zhe Ren. A novel quinolinylmethyl substituted ethylenediamine compound exerts anti-cancer effects via stimulating the accumulation of reactive oxygen species and NO in hepatocellular carcinoma cellsEuropean Journal of Pharmacology 2020; 885: 173497 doi: 10.1016/j.ejphar.2020.173497
26
Zhi-Bin Zhao, Jie Long, Yang-Yang Zhao, Jing-Bo Yang, Wei Jiang, Qing-Zhi Liu, Kai Yan, Liang Li, Yu-Cai Wang, Zhe-Xiong Lian. Adaptive immune cells are necessary for the enhanced therapeutic effect of sorafenib-loaded nanoparticlesBiomaterials Science 2018; 6(4): 893 doi: 10.1039/C8BM00106E
27
Jialiang Wang, Yifan Lian, Yurong Gu, Hongbo Wang, Lin Gu, Yanlin Huang, Liang Zhou, Yuehua Huang. Synergistic effect of farnesyl transferase inhibitor lonafarnib combined with chemotherapeutic agents against the growth of hepatocellular carcinoma cellsOncotarget 2017; 8(62): 105047 doi: 10.18632/oncotarget.22086
28
Yulong Zheng, Lihua Jiang, Yongxian Hu, Cheng Xiao, Nong Xu, Jianying Zhou, Xinhui Zhou. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathwayBMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3139-2
29
M. Gorgizadeh, N. Behzadpour, F. Salehi, F. Daneshvar, R. Dehdari Vais, R. Nazari-Vanani, N. Azarpira, M. Lotfi, N. Sattarahmady. A MnFe2O4/C nanocomposite as a novel theranostic agent in MRI, sonodynamic therapy and photothermal therapy of a melanoma cancer modelJournal of Alloys and Compounds 2020; 816: 152597 doi: 10.1016/j.jallcom.2019.152597
30
Saleh Daher, Muhammad Massarwa, Ariel A. Benson, Tawfik Khoury. Current and Future Treatment of Hepatocellular Carcinoma: An Updated Comprehensive ReviewJournal of Clinical and Translational Hepatology 2018; 6(1): 1 doi: 10.14218/JCTH.2017.00031
31
Ncobile Bagezile Mdlovu, Kuen-Song Lin, Meng-Tzu Weng, Ndumiso Vukile Mdlovu. Formulation and in-vitro evaluations of doxorubicin loaded polymerized magnetic nanocarriers for liver cancer cellsJournal of the Taiwan Institute of Chemical Engineers 2021; 126: 278 doi: 10.1016/j.jtice.2021.06.059
32
Meiwan Chen, Xingzhi Zhou, Ruie Chen, Junlin Wang, Richard D. Ye, Yitao Wang, Chuanbin Wu, Ram I. Mahato. Nano-carriers for delivery and targeting of active ingredients of Chinese medicine for hepatocellular carcinoma therapyMaterials Today 2019; 25: 66 doi: 10.1016/j.mattod.2018.10.040
33
Hui Guo, Yan Zhong, Amanda L. Jackson, Leslie H. Clark, Josh Kilgore, Lu Zhang, Jianjun Han, Xiugui Sheng, Timothy P. Gilliam, Paola A. Gehrig, Chunxiao Zhou, Victoria L. Bae-Jump. Everolimus exhibits anti-tumorigenic activity in obesity-induced ovarian cancerOncotarget 2016; 7(15): 20338 doi: 10.18632/oncotarget.7934
34
Soojung Lee, Judee Grace E. Nemeño, Jeong Ik Lee. Repositioning Bevacizumab: A Promising Therapeutic Strategy for Cartilage RegenerationTissue Engineering Part B: Reviews 2016; 22(5): 341 doi: 10.1089/ten.teb.2015.0300
35
Seong Min Kim, Sang Eun Ha, Ho Jeong Lee, Shailima Rampogu, Preethi Vetrivel, Hun Hwan Kim, Venu Venkatarame Gowda Saralamma, Keun Woo Lee, Gon Sup Kim. Sinensetin Induces Autophagic Cell Death through p53-Related AMPK/mTOR Signaling in Hepatocellular Carcinoma HepG2 CellsNutrients 2020; 12(8): 2462 doi: 10.3390/nu12082462
36
Petra Grbčić, Elitza Petkova Markova Car, Mirela Sedić. Targeting Ceramide Metabolism in Hepatocellular Carcinoma: New Points for Therapeutic InterventionCurrent Medicinal Chemistry 2020; 27(39): 6611 doi: 10.2174/0929867326666190911115722
37
Bang-Bin Chen, Chao-Yu Hsu, Chih-Wei Yu, Po-Chin Liang, Chiun Hsu, Chih-Hung Hsu, Ann-Lii Cheng, Tiffany Ting-Fang Shih. Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinomaEuropean Radiology 2017; 27(7): 3069 doi: 10.1007/s00330-016-4670-2
38
Xin Qing, Wenjing Xu, Jingjing Zong, Xuanlong Du, Hao Peng, Yewei Zhang. Emerging treatment modalities for systemic therapy in hepatocellular carcinomaBiomarker Research 2021; 9(1) doi: 10.1186/s40364-021-00319-3
39
Yuan Sun, Hai Xu, Xinju Chen, Xiaodong Li, Baoping Luo. Inhibition of mitochondrial respiration overcomes hepatocellular carcinoma chemoresistanceBiochemical and Biophysical Research Communications 2019; 508(2): 626 doi: 10.1016/j.bbrc.2018.11.182
40
Ting Xu, Shaojing Zhao, Changwei Lin, Xiuli Zheng, Minhuan Lan. Recent advances in nanomaterials for sonodynamic therapyNano Research 2020; 13(11): 2898 doi: 10.1007/s12274-020-2992-5
41
Yuchang Yan, Tao Jiang, Zhenghan Yang, Zhenchang Wang, Erhu Jin, Zhenyu Pan. Application of Gemstone CT Spectroscopy in the Evaluation of Abnormal Enhancement of Lesion Margin After Radiofrequency Ablation of Hepatocellular CarcinomaIranian Journal of Radiology 2020; 17(4) doi: 10.5812/iranjradiol.99611
42
Cheol Park, Ji-Suk Jeong, Jin-Woo Jeong, Sung Ok Kim, Yong-Joo Kim, Gi-Young Kim, Su-Hyun Hong, Yung Hyun Choi. Ethanol extract of Kalopanax septemlobus leaf inhibits HepG2 human hepatocellular carcinoma cell proliferation via inducing cell cycle arrest at G 1 phaseAsian Pacific Journal of Tropical Medicine 2016; 9(4): 344 doi: 10.1016/j.apjtm.2016.03.003
43
Yanxia Gong, Jie Zhang, Xiang Wu, Tao Wang, Jia Zhao, Zhi Yao, Qingyu Zhang, Xi Liu, Xu Jian. Specific expression of proton-coupled oligopeptide transporter 1 in primary hepatocarcinoma-a novel strategy for tumor-targeted therapyOncology Letters 2017; 14(4): 4158 doi: 10.3892/ol.2017.6724
44
Yongmei Li, Hao Zhuang, Xinran Zhang, Yuan Li, Yun Liu, Xianfu Yi, Guoxuan Qin, Wen Wei, Ruibing Chen. Multiomics Integration Reveals the Landscape of Prometastasis Metabolism in Hepatocellular CarcinomaMolecular & Cellular Proteomics 2018; 17(4): 607 doi: 10.1074/mcp.RA118.000586
45
M. Gorgizadeh, N. Azarpira, M. Lotfi, F. Daneshvar, F. Salehi, N. Sattarahmady. Sonodynamic cancer therapy by a nickel ferrite/carbon nanocomposite on melanoma tumor: In vitro and in vivo studiesPhotodiagnosis and Photodynamic Therapy 2019; 27: 27 doi: 10.1016/j.pdpdt.2019.05.023
46
Ying Han, Yinghui Peng, Yaojie Fu, Changjing Cai, Cao Guo, Shanshan Liu, Yiyi Li, Yihong Chen, Edward Shen, Kexin Long, Xinwen Wang, Jian Yu, Hong Shen, Shan Zeng. MLH1 Deficiency Induces Cetuximab Resistance in Colon Cancer via Her‐2/PI3K/AKT SignalingAdvanced Science 2020; 7(13): 2000112 doi: 10.1002/advs.202000112
47
Naomi Nishio, Tadao Hasegawa, Ichiro Tatsuno, Masanori Isaka, Ken-ichi Isobe. Female GADD34 mice develop age-related inflammation and hepatocellular carcinomaGeriatrics & Gerontology International 2017; 17(12): 2593 doi: 10.1111/ggi.13080
48
Zi Yin, Tingting Ma, Ye Lin, Xin Lu, Chuanzhao Zhang, Sheng Chen, Zhixiang Jian. IL‐6/STAT3 pathway intermediates M1/M2 macrophage polarization during the development of hepatocellular carcinomaJournal of Cellular Biochemistry 2018; 119(11): 9419 doi: 10.1002/jcb.27259
49
Bei Wang, Tan-Yang Zhou, Chun-Hui Nie, Da-Long Wan, Shu-Sen Zheng. Bigelovin, a sesquiterpene lactone, suppresses tumor growth through inducing apoptosis and autophagy via the inhibition of mTOR pathway regulated by ROS generation in liver cancerBiochemical and Biophysical Research Communications 2018; 499(2): 156 doi: 10.1016/j.bbrc.2018.03.091
50
Hardev Singh, Seo Jin Kim, Dong Hoon Kang, Hye-Ri Kim, Amit Sharma, Won Young Kim, Chulhun Kang, Jong Seung Kim. Glycyrrhetinic acid as a hepatocyte targeting unit for an anticancer drug delivery system with enhanced cell type selectivityChemical Communications 2018; 54(87): 12353 doi: 10.1039/C8CC05175E
51
Selin Oncul, Gulsah Karakaya, Mutlu Dilsiz Aytemir, Ayse Ercan. A kojic acid derivative promotes intrinsic apoptotic pathway of hepatocellular carcinoma cells without incurring drug resistanceChemical Biology & Drug Design 2019; 94(6): 2084 doi: 10.1111/cbdd.13615
52
Shubham Gupta, Sikandar Khan, Michal Kawka, Rohan Gujjuri, Ian Chau, Naureen Starling, David Cunningham, Long R Jiao, Tamara Gall. Clinical utility of clonal origin determination in managing recurrent hepatocellular carcinomaExpert Review of Gastroenterology & Hepatology 2021; 15(10): 1159 doi: 10.1080/17474124.2021.1967144
53
Heba Taha, Nourhan Elfar, Hesham Haffez, Zeineb A. Hassan. Raptinal silver nanoparticles: new therapeutic advances in hepatocellular carcinoma mouse modelNaunyn-Schmiedeberg's Archives of Pharmacology 2021; 394(2): 279 doi: 10.1007/s00210-020-01973-4
54
Sarina Mokhtari, Mehran Solati-Hashjin, Zahra Khosrowpour, Mazaher Gholipourmalekabadi. Layered double hydroxide-galactose as an excellent nanocarrier for targeted delivery of curcumin to hepatocellular carcinoma cellsApplied Clay Science 2021; 200: 105891 doi: 10.1016/j.clay.2020.105891
55
Praful R. Nair, Cory Alvey, Xiaoling Jin, Jerome Irianto, Irena Ivanovska, Dennis E. Discher. Filomicelles Deliver a Chemo-Differentiation Combination of Paclitaxel and Retinoic Acid That Durably Represses Carcinomas in Liver to Prolong SurvivalBioconjugate Chemistry 2018; 29(4): 914 doi: 10.1021/acs.bioconjchem.7b00816
56
Jun Young Park, Ju Ri Chae, Ye Lim Cho, Youndong Kim, Dasom Lee, Jeong Kyun Lee, Won Jun Kang. Targeted Therapy of Hepatocellular Carcinoma Using Gemcitabine-Incorporated GPC3 AptamerPharmaceutics 2020; 12(10): 985 doi: 10.3390/pharmaceutics12100985
57
Bingting Yu, Ruslan Mamedov, Gwenny M. Fuhler, Maikel P. Peppelenbosch. Drug Discovery in Liver Disease Using Kinome ProfilingInternational Journal of Molecular Sciences 2021; 22(5): 2623 doi: 10.3390/ijms22052623
58
Caixia Xia, Liyan Shui, Guohua Lou, Bingjue Ye, Wei Zhu, Jing Wang, Shanshan Wu, Xiao Xu, Long Mao, Wanhong Xu, Zhi Chen, Yanning Liu, Min Zheng. 0404 inhibits hepatocellular carcinoma through a p53/miR-34a/SIRT1 positive feedback loopScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-04487-x
59
Iftikhar Ali Khawar, Jong Kook Park, Eun Sun Jung, Myung Ah Lee, Suhwan Chang, Hyo-Jeong Kuh. Three Dimensional Mixed-Cell Spheroids Mimic Stroma-Mediated Chemoresistance and Invasive Migration in hepatocellular carcinomaNeoplasia 2018; 20(8): 800 doi: 10.1016/j.neo.2018.05.008
60
Hongzhi Du, Yue Huang, Xiaoying Hou, Xingping Quan, Jingwei Jiang, Xiaohui Wei, Yang Liu, Hongyang Li, Puhai Wang, Meixiao Zhan, Xun Ai, Ligong Lu, Shengtao Yuan, Li Sun. Two novel camptothecin derivatives inhibit colorectal cancer proliferation via induction of cell cycle arrest and apoptosis in vitro and in vivoEuropean Journal of Pharmaceutical Sciences 2018; 123: 546 doi: 10.1016/j.ejps.2018.08.018
61
Yang Liu, Heng Yang, Qiang Guo, Tingting Liu, Yong Jiang, Mingbo Zhao, Kewu Zeng, Pengfei Tu. Cucurbitacin E Inhibits Huh7 Hepatoma Carcinoma Cell Proliferation and Metastasis via Suppressing MAPKs and JAK/STAT3 PathwaysMolecules 2020; 25(3): 560 doi: 10.3390/molecules25030560
62
K. K. Dar, S. Ali, M. Ejaz, S. Nasreen, N. Ashraf, S. F. Gillani, N. Shafi, S. Safeer, M. A. Khan, S. Andleeb, T. A. Mughal. In vivo induction of hepatocellular carcinoma by diethylnitrosoamine and pharmacological intervention in Balb C mice using Bergenia ciliata extractsBrazilian Journal of Biology 2019; 79(4): 629 doi: 10.1590/1519-6984.186565
63
Hui Tong, Tao Li, Weihua Qiu, Zhecheng Zhu. Claudin‑1 silencing increases sensitivity of liver cancer HepG2 cells to 5‑fluorouracil by inhibiting autophagyOncology Letters 2019;  doi: 10.3892/ol.2019.10967
64
Li Wang, Yaqiong Zhan, Zhe Wu, Mengjia Lin, Xuehang Jin, Lushun Jiang, Yunqing Qiu. A novel multitarget kinase inhibitor BZG with potent anticancer activity in vitro and vivo enhances efficacy of sorafenib through PI3K pathways in hepatocellular carcinoma cellsBiomedicine & Pharmacotherapy 2020; 125: 110033 doi: 10.1016/j.biopha.2020.110033
65
Jasmine Baby, Aswathy R. Devan, Ayana R. Kumar, Jaggaiah N. Gorantla, Bhagyalakshmi Nair, Thanatharayil Sathian Aishwarya, Lekshmi R. Nath. Cogent role of flavonoids as key orchestrators of chemoprevention of hepatocellular carcinoma: A reviewJournal of Food Biochemistry 2021; 45(7) doi: 10.1111/jfbc.13761
66
Hirayuki Enomoto, Hideji Nakamura, Weidong Liu, Shuhei Nishiguchi. Hepatoma-Derived Growth Factor: Its Possible Involvement in the Progression of Hepatocellular CarcinomaInternational Journal of Molecular Sciences 2015; 16(12): 14086 doi: 10.3390/ijms160614086
67
Mou-Bo Si, Pei-Jing Yan, Xiang-Yong Hao, Zhen-Ying Du, Hong-Wei Tian, Jia Yang, Cai-Wen Han, Ke-Hu Yang, Tian-Kang Guo. Efficacy and safety of radiofrequency ablation versus minimally invasive liver surgery for small hepatocellular carcinoma: a systematic review and meta-analysisSurgical Endoscopy 2019; 33(8): 2419 doi: 10.1007/s00464-019-06784-0
68
Hongliang Du, Mengrui Liu, Aihua Yu, Jianbo Ji, Guangxi Zhai. Insight into the role of dual-ligand modification in low molecular weight heparin based nanocarrier for targeted delivery of doxorubicinInternational Journal of Pharmaceutics 2017; 523(1): 427 doi: 10.1016/j.ijpharm.2017.03.065
69
Jian Zhang, Chunyan Fang, Meihua Qu, Huina Wu, Xuejuan Wang, Hongan Zhang, Hui Ma, Zhaolin Zhang, Yongxue Huang, Lihong Shi, Shujuan Liang, Zhiqin Gao, Weiguo Song, Xuejian Wang. CD13 Inhibition Enhances Cytotoxic Effect of Chemotherapy AgentsFrontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.01042
70
Hongyan Xue, Guo-Yan Tian. MiR-429 regulates the metastasis and EMT of HCC cells through targeting RAB23Archives of Biochemistry and Biophysics 2018; 637: 48 doi: 10.1016/j.abb.2017.11.011
71
Yu-Chun Lin, Bao-Hong Lee, Jassey Alagie, Ching-Hua Su. Combination treatment of ergosterol followed by amphotericin B induces necrotic cell death in human hepatocellular carcinoma cellsOncotarget 2017; 8(42): 72727 doi: 10.18632/oncotarget.20285
72
Mahfoozur Rahman, Waleed H Almalki, Majed Alrobaian, Jawed Iqbal, Saad Alghamdi, Khalid S Alharbi, Nabil K Alruwaili, Abdul Hafeez, Adil Shaharyar, Tanuja Singh, Mohammad Waris, Vikas Kumar, Sarwar Beg. Nanocarriers-loaded with natural actives as newer therapeutic interventions for treatment of hepatocellular carcinomaExpert Opinion on Drug Delivery 2021; 18(4): 489 doi: 10.1080/17425247.2021.1854223
73
Yu-xian Huang, Xin-tong Chen, Kun-yuan Guo, Yu-hua Li, Bing-yi Wu, Chao-yang Song, Yan-jie He. Sunitinib Induces NK-κB-dependent NKG2D Ligand Expression in Nasopharyngeal Carcinoma and Hepatoma CellsJournal of Immunotherapy 2017; 40(5): 164 doi: 10.1097/CJI.0000000000000168
74
Stephanie H. Greco, Kristen Spencer, Darren R. Carpizo. Precision Molecular Pathology of Liver CancerMolecular Pathology Library 2018; : 235 doi: 10.1007/978-3-319-68082-8_13
75
CHEOL PARK, JI-SUK JEONG, JIN-WOO JEONG, YONG-JOO KIM, YEON-KWON JUNG, GEUN-BAE GO, SUNG OK KIM, GI-YOUNG KIM, SU-HYUN HONG, YOUNG HYUN YOO, YUNG HYUN CHOI. Ethanol extract of Kalopanax septemlobus leaf induces caspase-dependent apoptosis associated with activation of AMPK in human hepatocellular carcinoma cellsInternational Journal of Oncology 2016; 48(1): 261 doi: 10.3892/ijo.2015.3233
76
L. V. K. S. Bhaskar, L. Saikrishna. Role of Tyrosine Kinases in Gastrointestinal Malignancies2018; : 191 doi: 10.1007/978-981-13-1486-5_14
77
Galina Khemlina, Sadakatsu Ikeda, Razelle Kurzrock. The biology of Hepatocellular carcinoma: implications for genomic and immune therapiesMolecular Cancer 2017; 16(1) doi: 10.1186/s12943-017-0712-x
78
Ivan Haralampiev, Holger A. Scheidt, Tobias Abel, Madlen Luckner, Andreas Herrmann, Daniel Huster, Peter Müller. The interaction of sorafenib and regorafenib with membranes is modulated by their lipid compositionBiochimica et Biophysica Acta (BBA) - Biomembranes 2016; 1858(11): 2871 doi: 10.1016/j.bbamem.2016.08.014
79
Chaoting Zeng, Wenting Shang, Xiaoyuan Liang, Xiao Liang, Qingshan Chen, Chongwei Chi, Yang Du, Chihua Fang, Jie Tian. Cancer Diagnosis and Imaging-Guided Photothermal Therapy Using a Dual-Modality NanoparticleACS Applied Materials & Interfaces 2016; 8(43): 29232 doi: 10.1021/acsami.6b06883
80
Xinjun Dong, Feiyan Liu, Mianli Li. Inhibition of nuclear factor κB transcription activity drives a synergistic effect of cisplatin and oridonin on HepG2 human hepatocellular carcinoma cellsAnti-Cancer Drugs 2016; 27(4): 286 doi: 10.1097/CAD.0000000000000329
81
Da Huo, Jianfeng Zhu, Guojun Chen, Qian Chen, Chao Zhang, Xingyu Luo, Wei Jiang, Xiqun Jiang, Zhen Gu, Yong Hu. Eradication of unresectable liver metastasis through induction of tumour specific energy depletionNature Communications 2019; 10(1) doi: 10.1038/s41467-019-11082-3
82
Shruthi Kanthaje, Ankita Makol, Anuradha Chakraborti. Sorafenib response in hepatocellular carcinoma: MicroRNAs as tuning forksHepatology Research 2018; 48(1): 5 doi: 10.1111/hepr.12991
83
Nicoletta Depalo, Rosa Maria Iacobazzi, Gianpiero Valente, Ilaria Arduino, Silvia Villa, Fabio Canepa, Valentino Laquintana, Elisabetta Fanizza, Marinella Striccoli, Annalisa Cutrignelli, Angela Lopedota, Letizia Porcelli, Amalia Azzariti, Massimo Franco, Maria Lucia Curri, Nunzio Denora. Sorafenib delivery nanoplatform based on superparamagnetic iron oxide nanoparticles magnetically targets hepatocellular carcinomaNano Research 2017; 10(7): 2431 doi: 10.1007/s12274-017-1444-3
84
Jie Qiao, Jie Liu, Kaiqiao Jia, Ning Li, Bin Liu, Qingyu Zhang, Runzhi Zhu. Diosmetin triggers cell apoptosis by activation of the p53/Bcl-2 pathway and inactivation of the Notch3/NF-κB pathway in HepG2 cellsOncology Letters 2016; 12(6): 5122 doi: 10.3892/ol.2016.5347
85
Giuseppe Tarantino, Paolo Magistri, Roberto Ballarin, Raffaele Di Francia, Massimiliano Berretta, Fabrizio Di Benedetto. Oncological Impact of M-Tor Inhibitor Immunosuppressive Therapy after Liver Transplantation for Hepatocellular Carcinoma: Review of the LiteratureFrontiers in Pharmacology 2016; 7 doi: 10.3389/fphar.2016.00387
86
So Young Yoo, Narayanasamy Badrinath, Hyun Young Woo, Jeong Heo. Oncolytic Virus-Based Immunotherapies for Hepatocellular CarcinomaMediators of Inflammation 2017; 2017: 1 doi: 10.1155/2017/5198798
87
Lili Cao, Lijun Zhang, Xiang Zhao, Ye Zhang, Daolin Tang. A Hybrid Chalcone Combining the Trimethoxyphenyl and Isatinyl Groups Targets Multiple Oncogenic Proteins and Pathways in Hepatocellular Carcinoma CellsPLOS ONE 2016; 11(8): e0161025 doi: 10.1371/journal.pone.0161025
88
Emanuele Rinninella, Lucia Cerrito, Irene Spinelli, Marco Cintoni, Maria Cristina Mele, Maurizio Pompili, Antonio Gasbarrini. Chemotherapy for Hepatocellular Carcinoma: Current Evidence and Future PerspectivesJournal of Clinical and Translational Hepatology 2017; (XX): 1 doi: 10.14218/JCTH.2017.00002
89
Shaimaa Yousef, Hashem O. Alsaab, Samaresh Sau, Arun K. Iyer. Development of asialoglycoprotein receptor directed nanoparticles for selective delivery of curcumin derivative to hepatocellular carcinomaHeliyon 2018; 4(12): e01071 doi: 10.1016/j.heliyon.2018.e01071
90
Hongzhi Wang, Satheesh Ellipilli, Wen-Jui Lee, Xin Li, Mario Vieweger, Yuan-Soon Ho, Peixuan Guo. Multivalent rubber-like RNA nanoparticles for targeted co-delivery of paclitaxel and MiRNA to silence the drug efflux transporter and liver cancer drug resistanceJournal of Controlled Release 2021; 330: 173 doi: 10.1016/j.jconrel.2020.12.007
91
Qingqing Xiong, Mangmang Cui, Ge Yu, Jian Wang, Tianqiang Song. Facile Fabrication of Reduction-Responsive Supramolecular Nanoassemblies for Co-delivery of Doxorubicin and Sorafenib toward Hepatoma CellsFrontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00061
92
I-Tao Huang, Bijay Dhungel, Ritu Shrestha, Kim R. Bridle, Darrell H. G. Crawford, Aparna Jayachandran, Jason C Steel. Spotlight on Bortezomib: potential in the treatment of hepatocellular carcinomaExpert Opinion on Investigational Drugs 2019; 28(1): 7 doi: 10.1080/13543784.2019.1551359
93
Zhi-Peng Sun, Jian Zhang, Li-Hong Shi, Xiu-Rong Zhang, Yu Duan, Wen-Fang Xu, Gong Dai, Xue-Jian Wang. Aminopeptidase N inhibitor 4cc synergizes antitumor effects of 5-fluorouracil on human liver cancer cells through ROS-dependent CD13 inhibitionBiomedicine & Pharmacotherapy 2015; 76: 65 doi: 10.1016/j.biopha.2015.10.023
94
Mi-Jin Kim, Yeon-Kyung Choi, Soo Young Park, Se Young Jang, Jung Yi Lee, Hye Jin Ham, Byung-Gyu Kim, Hui-Jeon Jeon, Ji-Hyun Kim, Jung-Guk Kim, In-Kyu Lee, Keun-Gyu Park. PPARδ Reprograms Glutamine Metabolism in Sorafenib-Resistant HCCMolecular Cancer Research 2017; 15(9): 1230 doi: 10.1158/1541-7786.MCR-17-0061
95
Meng Niu, Duo Hong, Teng-Chuang Ma, Xiao-Wei Chen, Jin-Hang Han, Jun Sun, Ke Xu. Short-term and long-term efficacy of 7 targeted therapies for the treatment of advanced hepatocellular carcinomaMedicine 2016; 95(49): e5591 doi: 10.1097/MD.0000000000005591
96
Jesmin Mondal, Anisur Rahman Khuda-Bukhsh. Cisplatin and farnesol co-encapsulated PLGA nano-particles demonstrate enhanced anti-cancer potential against hepatocellular carcinoma cells in vitroMolecular Biology Reports 2020; 47(5): 3615 doi: 10.1007/s11033-020-05455-x
97
Robert F. Schwabe, Tom Luedde. Apoptosis and necroptosis in the liver: a matter of life and deathNature Reviews Gastroenterology & Hepatology 2018; 15(12): 738 doi: 10.1038/s41575-018-0065-y
98
Tao Wang, Sicong Ma, Xingxing Qi, Xiaoyin Tang, Dan Cui, Zhi Wang, Jiachang Chi, Ping Li, Bo Zhai. Knockdown of the differentially expressed gene TNFRSF12A inhibits hepatocellular carcinoma cell proliferation and migration in vitroMolecular Medicine Reports 2017; 15(3): 1172 doi: 10.3892/mmr.2017.6154
99
Novi Angeline, Sung-Sik Choo, Cheol-Hwi Kim, Suk Ho Bhang, Tae-Hyung Kim. Precise Electrical Detection of Curcumin Cytotoxicity in Human Liver Cancer CellsBioChip Journal 2021; 15(1): 52 doi: 10.1007/s13206-021-00002-7
100
Guoxuan Qin, Mengjiao Dang, Huajun Gao, Hao Wang, Fengting Luo, Ruibing Chen. Deciphering the protein–protein interaction network regulating hepatocellular carcinoma metastasisBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics 2017; 1865(9): 1114 doi: 10.1016/j.bbapap.2017.06.005